Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

1 Views
administrator
administrator
08/09/23

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next